The Day & Zimmermann Group, Inc.

Philadelphia, PA Professional servicesNAICS 541990

Self-funded health planPlan year 2025Renews January
12,556Participants+0% vs. prior year
$29.8MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#1 of 37Professional services in PABy participants

Overview

The Day & Zimmermann Group, Inc. sponsors a self-funded health plan that covered 12,556 participants in plan year 2025, about the same as the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
12,556 · prior year 12,517
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
The Day & Zimmermann Group, Inc. Welfare Benefits Plan, plan 517 (12,556 participants)
Stop-loss carrier
Wellpoint Stop Loss
Broker compensation
$492K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityPrepaid legalLong-term disabilityDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Metropolitan Life Insurance CompanyMedical, Short-term disability, Long-term disability, Life7,280$4.1M$304K
Wellpoint Stop LossStop-loss3,921$825K$41K
Cigna Health and Life Insurance CompanyMedical, Prescription drug, Dental55$425K$12K
Eyemed Vision CareVision8,492$391K$36K
Mertropolitan Life Insurance CompanyCritical Illness1,939$353K$64K
MetLife Legal Plans, Inc.Legal Plan572$115K$14K
New York Life (life Insurance Company of North America)Business Travel Accident12,556$26K$21K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$29.8M/ year

Estimated prescription spend: 12,556 participants × $2,371 national average per member. Usually higher once dependents are counted.

$774K–$1.9M/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$226K–$566K
Lower-cost therapeutic alternatives$330K–$691K
Generic pricing vs. actual cost$143K–$429K
PBM contract terms$74K–$223K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
The Day & Zimmermann Group, Inc.
Sponsor EIN
23-3024522
Plan number
517
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 23-3024522 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Day & Zimmermann Retirement Plan
Type
401(k) plan
Participants
5,690

About this data

Source: The Day & Zimmermann Group, Inc.'s Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with The Day & Zimmermann Group, Inc..

Request a correction · Methodology